Drug Design Congress at BAU

The 2nd International Bahçeşehir University Drug Design Congress was held on 17–19 April.

As average life expectancy increases, so do the health problems faced in old age and the risk of disease. For this reason, interest in academia and industry is growing in innovative and rational drug research and development aimed at new treatment mechanisms and the discovery of new therapies.

Held on 17–19 April 2014at the Bahçeşehir University (BAU) School of Medicine, the2nd International BAU Drug Design Congress (had as its main theme the latest developments in structure- and ligand-based drug design techniques, methods and applications. The congress was open to all researchers from the different disciplines involved in drug research and served as a platform for developing joint projects among scientists working experimentally and theoretically in academia and industry.

The goal of the congress is to contribute to new scientific discoveries by discussing the latest innovations, developments, applications and approaches in drug design. This goal also reflects Bahçeşehir University's strategic priority of interdisciplinary research and integration in the basic and clinical sciences.